Methylselenocysteine

DB12697InvestigationalSmall molecule

Methylselenocysteine has been used in trials studying the prevention of Prostate Carcinoma and No Evidence of Disease.

Chemical structure of Methylselenocysteine
Mechanism
Curator reviewed
Formula / weight
C4H9NO2Se · 182.08 g/mol (avg)

Resolves to

Compound
UNIITWK220499ZCAS26046-90-2ChEMBLCHEMBL62382ChEBI27812PubChem147004KEGGC05689
Structure
InChIKeyXDSSPSLGNGIIHP-VKHMYHEASA-NSMILESC[Se]C[C@H](N)C(O)=O
Targets
P24941CDK2

What you can answer from here — as of July 27, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
40Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Methylselenocysteine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In